Charities Ensnared In NJ Antitrust Suit Over Cancer Drugs
Two nonprofits have been added to a sweeping antitrust lawsuit accusing Celgene Corp. and parent Bristol-Myers Squibb Co. of stifling generic competition for two blockbuster cancer drugs and driving up prices...To view the full article, register now.
Already a subscriber? Click here to view full article